Radiologic Assessment of the Genitourinary Diaphragm Using MRI with Endorectal Coil in Men with Localized Prostate Cancer ASTRO Annual Meeting 2014, #3792.

Slides:



Advertisements
Similar presentations
Impact of cytokeratin-positive cells in bone marrow on survival in patients with non-metastatic prostate cancer treated by radiotherapy PURPOSE To evaluate.
Advertisements

Magnetic resonance imaging detects significant prostate cancer and could be used to reduce unnecessary biopsies: Initial results from a prospective trial.
Is Radical Prostatectomy Adequate For High Risk Prostate Cancer?
Management of locally advanced & metastatic prostate cancer Dr. Purvish. M. Parikh MD, DNB, PhD, FICP Professor & Head Department of Medical Oncology Tata.
Introduction Treatment of metastatic prostate cancer with androgen deprivation therapy (ADT) is effective, but can be associated with debilitating side.
In the past few years the usage of conformal and IMRT treatments has been increasing rapidly. These treatments employ the use of tighter margins around.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Radiotherapy in prostate cancer Dr.Mina Tajvidi Radiation oncologist.
Role of MRI and MRSI in The Management of Prostate Cancer Karim Touijer, MD.
Steven Joniau Filip Ameye
Radiation and Prostate Cancer Past, Present and Future Dr
1. Controversies in Prostate Cancer Radiation Therapy April 24, 2013 Lancaster General Health CME Curtiland Deville, MD Assistant Professor.
Prostate Cancer Int. 洪 毓 謙. Prostate cancer is the Second leading cause of death from cancer in the United States American male, the lifetime risk of:
Controversies in the management of PSA-only recurrent disease Stephen J. Freedland, MD Associate Professor of Urology and Pathology Durham VA Medical Center.
The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99 mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT,
Evaluating a Nomogram for the Development of Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Treated with 3D and Intensity Modulated.
Routine Use of Intraoperative Ultrasound Guidance during Intracavitary Brachytherapy Applicator Placement in Cervical Cancer: the University of Alabama.
Comparison of Outcomes between Brachytherapy and Intensity Modulated Radiotherapy in High Risk Prostate Cancer M. A. Weller, C. A. Reddy, J. Kittel, K.
The Role of Ultrasound of the Regional Nodal Basins in Staging Patients with Triple Negative Breast Cancer: Implications for Local-Regional Treatment Simona.
Quantifying of avascular necrosis of femoral head The clinical problem Determining the risk of femoral head collapse in a patient with AVNFH.
Dan Spratt, MD Department of Radiation Oncology Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging.
MRI SIMULATION FOR CONFORMAL RADIATION THERAPY OF PROSTATE CANCER Pasquier D 1-3, Palos G 3, Castelain B 1, Lartigau E 1,2, Rousseau J 2,3 1 Department.
BREAST MRI IN RADIATION THERAPY PLANNING MARSHA HALEY, M.D. ASSISTANT PROFESSOR UNIVERSITY OF PITTSBURGH CANCER INSTITUTE PITTSBURGH, PENNSYLVANIA, USA.
MRI-Ultrasound Fusion-Guided Biopsy of the Prostate: Results of Initial Experience in a Radiation Oncology Department Department of Radiation Oncology.
Updated 5-year Biochemical Relapse-Free Survival after Prostate Brachytherapy Jenny P. Nobes St. Luke’s Cancer Centre, The Royal Surrey County Hospital,
Ten Year Outcomes In Men Under 60 Treated With Iodine-125 Permanent Brachytherapy As Monotherapy GU - Prostate Cancer: Novel Imaging (MRI,PET) & Brachytherapy.
PROSTATE CANCER: RADIATION THERAPY APPROACHES ANDREW L. SALNER, MD FACR DIRECTOR HELEN & HARRY GRAY CANCER CENTER HARTFORD HOSPITAL, CT.
Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.
A prospective randomized trial
Adjuvant High-Dose-Rate Brachytherapy Alone for Stage I/II Endometrial Adenocarcinoma using a 4-Gray versus 6-Gray Fractionation Scheme Marie Lynn Racine,
Long-Term versus Short-Term Androgen Deprivation Combined with High-Dose Radiotherapy for Intermediate and High Risk Prostate Cancer: Preliminary Results.
Introduction/Aims There is less written about failure patterns after prostate brachytherapy (BT) alone or in combination with external beam radiotherapy.
FREEDOM FROM PROGRESSION FOR PATIENTS RECEIVING I 125 VERSUS Pd 103 FOR PROSTATE BRACHYTHERAPY Jane Cho, Carol Morgenstern, Barbara Napolitano, Lee Richstone,
High Dose Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes Tania Kaprealian 1, Vivian Weinberg 3, Joycelyn.
J. Lujan, G. Valero, Q. Hernandez, A. Sanchez, M.D. Frutos and P. Parrilla. British Journal of Surgery, September 2009.
Understanding Prostate Myths
The Role of Cyberknife Stereotactic Body Radiation Therapy in the Treatment of Localized Prostate Cancer David M. Spellberg M.D., FACS Naples Urology Associates,
The Role of Cyberknife Stereotactic Body Radiation Therapy in the Treatment of Prostate Cancer Jay L. Friedland, MD.
Image Guided Interstitial Brachytherapy For Locally Advanced Gynaecological Cancer With A MUPIT Applicator M.A.D. Haverkort, MD 1, E. Van der Steen - Banasik,
IMPACT OF STAGE MIGRATION ON NODE POSITIVE PROSTATE CANCER RATE AND FEATURES: A 20-YEAR, SINGLE INSTITUTION ANALYSIS IN MEN TREATED WITH EXTENDED PELVIC.
The Role of Cyberknife Stereotactic Body Radiation Therapy in the Treatment of Localized Prostate Cancer David M. Spellberg M.D., FACS.
Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.
MAGNETIC RESONANCE IMAGING IN RADIATION TREATMENT
Volume 64, Issue 5, Pages (November 2013)
Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with.
Modern Radiation Oncology
Radiation therapy for Early Stage Prostate Cancer
Surgical Treatment in Locally Advanced Prostate Cancer
Radiological Sciences Department Ph.D., Paris-Sud 11 University
Director Department of Pediatric Hematology & Oncology Delhi, INDIA.
Introduction and Objectives
RELAZIONE TRA “STAGE MIGRATION” E
RTOG 0126 A Phase III Randomized Study of High Dose 3D-CRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer Bijoy.
Prostate Cancer: Highlights from 2006
Median Volume (cc) of GTV Receiving Dose
Insert tables Insert graphs Insert figure
Figure 3 Semantic model of the active surveillance (AS) timeline
Dynamic Contrast-Enhanced MRI for Preoperative Identification of Localised Prostate Cancer  Arnauld Villers, Philippe Puech, Xavier Leroy, Jacques Biserte,
Volume 64, Issue 5, Pages (November 2013)
Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.
Volume 67, Issue 6, Pages (June 2015)
Volume 67, Issue 4, Pages (April 2015)
Volume 64, Issue 6, Pages (December 2013)
EARLY AND LATE COMPLICATIONS OF PROSTATE LOW DOSE BRACHYTHERAPY
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
Clinical and radiobiological evaluation of a method for planning target volume generation dependent on organ-at-risk exclusions in magnetic resonance.
Volume 53, Issue 6, Pages (June 2008)
Constantinos Zamboglou, Matthias Eiber, Thomas R
History: 71 yo male post radical prostatectomy 4 years ago for Gleason 4+5 prostate cancer Pre-op staging CT and MDP bone scan were negative for metastatic.
Jesse Conterato, BA&Sc. RSNA 2016
Presentation transcript:

Radiologic Assessment of the Genitourinary Diaphragm Using MRI with Endorectal Coil in Men with Localized Prostate Cancer ASTRO Annual Meeting 2014, #3792 September 17, 2014 Neil K. Taunk MD MS, Oguz Akin MD, Xin Pei PhD, Michael Zelefsky MD

Assessing the Genitourinary diaphragm Identification of the prostate apex is critical in radiotherapy planning ‒ Overestimation can lead to unnecessary dose to the penile bulb ‒ Underestimation leads to undertreatment of the prostate apex Genitourinary diaphragm (GUD) is the distance between the prostate apex and the penile bulb – Also known as the membranous urethra length (MUL) – Discordant measurements with expert guidelines, retrograde urethrography, bony landmarks, ultrasound localization, CT-based planning MRI prostate improves identification of prostate anatomy* – Reduces systematic overestimation of prostate size at the apex – Endorectal coil improves T2-weighted spatial resolution and apex delineation Assessment of the GUD using MRI with endorectal coil – Characterize the length of the GUD/MUL – Evaluate whether patient specific characteristics are related to GUD length

MR-based assessment MRI prostate improves identification of prostate anatomy* – Reduces systematic overestimation of prostate size at the apex – Improves delineation of the prostate-rectal interface Endorectal coil improves T2-weighted spatial resolution – Primarily used to examine for extracapsular extension and SVI, for more accurate staging – Also improves delineation of the prostate apex Assessment of the GUD using MRI with endorectal coil – Characterize the length of the GUD/MUL – Evaluate whether patient specific characteristics are related to GUD length *Roach IJROBP 1996; McLaughlin IJROBP 2010

Patients and Methods Patients with clinically localized prostate cancer – GS 6 or 7, cT1c-cT2b, PSA <20 – Disease and demographic information collected Imaging modality – 3T or 1.5T MRI – Endorectal coil – Axial, sagittal, and coronal T2-weighted images GUD length measured on sagittal and coronal T2-weight images – Patients excluded if significant TURP defect or significant artifact the prostate apex Assessment – Two independent raters measured GUD length Treatment – All patients were treated with definitive dose-escalated external beam radiotherapy ( Gy) +/- androgen deprivation therapy +/- pelvic lymph node treatment

Sagittal and Coronal T2-Weighted Imaging 75 yo M with cT1c GS (3+4)=7 prostate adenocarcinoma

Results: Interobserver Agreement and Demographics Two independent observers measured each GUD – Random sampling of patients resulted in excellent concordance (Spearman ρ = 0.834; p<0.001) – >85% interobserver agreement within 2mm No significant association with age, T-stage, Gleason score, NCCN risk group, height, weight (p=NS)

Results: GUD Characteristics Characteristic Median15mm Mean15.3mm Std Dev4mm Min3mm Max28mm

Conclusions Mean and median GUD length is 15mm Largest series to date of GUD length assessment in men Target volume delineation of the prostate is critical in radiotherapy planning Prostate MRI with endorectal coil is an excellent modality to delineate the prostate apex and GUD length

Acknowledgements MSKCC Department of Radiation Oncology ‒ Michael Zelefsky MD ‒ Xin (Isaac) Pei PhD MSKCC Department of Radiology – Oguz Akin MD